- $8.58m
- $34.74m
- $80.68m
- 11
- 89
- 26
- 37
Annual income statement for Upexi, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | R2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.21 | 7.41 | 24.1 | 23.1 | 80.7 |
Cost of Revenue | |||||
Gross Profit | 1.04 | 2.57 | 11.9 | 14.9 | 33.6 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2.8 | 12.8 | 21.9 | 29.3 | 94.4 |
Operating Profit | -0.589 | -5.43 | 2.22 | -6.19 | -13.7 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.587 | -5.38 | 1.7 | -6.39 | -18.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.587 | -5.38 | 2.98 | -5.87 | -15.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.587 | -5.38 | 2.98 | -2.1 | -16.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.587 | -5.38 | 2.93 | -2.1 | -16.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.041 | -0.35 | 0.169 | -0.377 | -0.607 |
Dividends per Share |